Harmony Biosciences (HRMY) News Today $38.77 -0.77 (-1.95%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$38.77 0.00 (0.00%) As of 01/31/2025 05:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period SG Americas Securities LLC Purchases 6,774 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)SG Americas Securities LLC increased its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 43.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 22,498 shares of the company's stock after buying an additional 6,774 shares during tJanuary 30 at 3:31 AM | marketbeat.comInsider Selling: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) CFO Sells 1,775 Shares of StockJanuary 29 at 4:59 AM | insidertrades.comHarmony Biosciences (NASDAQ:HRMY) Receives "Buy" Rating from HC WainwrightJanuary 29 at 2:31 AM | americanbankingnews.comHarmony Biosciences' chief commercial officer sells $551,575 in stockJanuary 28, 2025 | msn.comInsider Selling: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Sells 1,629 Shares of StockHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) insider Jeffrey Dierks sold 1,629 shares of the stock in a transaction that occurred on Monday, January 27th. The stock was sold at an average price of $38.02, for a total value of $61,934.58. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.January 28, 2025 | marketbeat.comSandip Kapadia Sells 1,775 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) StockHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) CFO Sandip Kapadia sold 1,775 shares of the company's stock in a transaction on Monday, January 27th. The shares were sold at an average price of $38.05, for a total value of $67,538.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.January 28, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Jeffrey Dierks Sells 13,125 SharesHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) insider Jeffrey Dierks sold 13,125 shares of Harmony Biosciences stock in a transaction on Friday, January 24th. The stock was sold at an average price of $37.31, for a total value of $489,693.75. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.January 28, 2025 | marketbeat.comHarmony Biosciences Holdings: A Promising Future Driven by WAKIX Expansion and Innovative PipelineJanuary 28, 2025 | markets.businessinsider.comH.C. Wainwright maintains $75 target on Harmony Biosciences stockJanuary 27, 2025 | msn.comHarmony Biosciences' (HRMY) Buy Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $75.00 target price on shares of Harmony Biosciences in a report on Monday.January 27, 2025 | marketbeat.comPacer Advisors Inc. Purchases 351,582 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Pacer Advisors Inc. grew its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 18.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,279,918 shares of the company's stock afJanuary 27, 2025 | marketbeat.comHarmony Biosciences CFO Sandip Kapadia sells $1m in stockJanuary 25, 2025 | msn.comIs Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Recent Stock Performance Tethered To Its Strong Fundamentals?January 25, 2025 | uk.finance.yahoo.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $55.00 Average Target Price from BrokeragesJanuary 25, 2025 | americanbankingnews.comHarmony Biosciences: Don't Sleep On This Enterprising, Profitable BiotechJanuary 24, 2025 | seekingalpha.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) CEO Jeffrey M. Dayno Sells 19,293 SharesJanuary 24, 2025 | insidertrades.comCantor Fitzgerald Estimates HRMY FY2025 EarningsJanuary 24, 2025 | americanbankingnews.comInsider Selling: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) CEO Sells 19,293 Shares of StockHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) CEO Jeffrey M. Dayno sold 19,293 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $40.13, for a total value of $774,228.09. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.January 23, 2025 | marketbeat.comSandip Kapadia Sells 25,000 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) StockHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) CFO Sandip Kapadia sold 25,000 shares of the business's stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $40.18, for a total transaction of $1,004,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.January 23, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Trading Down 4.5% - Here's What HappenedHarmony Biosciences (NASDAQ:HRMY) Trading Down 4.5% - Here's WhyJanuary 23, 2025 | marketbeat.com3 Under-the-Radar Biotech Stocks Revolutionizing HealthcareJanuary 22, 2025 | stocknews.comResearch Analysts Offer Predictions for HRMY FY2025 EarningsHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Harmony Biosciences in a research note issued to investors on Tuesday, January 21st. Cantor Fitzgerald analyst C. Duncan anticipates that the company will post earnJanuary 22, 2025 | marketbeat.comJeffrey Dierks Sells 1,123 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) StockJanuary 22, 2025 | insidertrades.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Recommendation of "Buy" from AnalystsShares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) have received an average recommendation of "Buy" from the eight analysts that are currently covering the stock, MarketBeat Ratings reports. Eight research analysts have rated the stock with a buy rating. The average 1-yeaJanuary 22, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Jeffrey Dierks Sells 1,123 SharesHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) insider Jeffrey Dierks sold 1,123 shares of the stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $40.00, for a total value of $44,920.00. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.January 21, 2025 | marketbeat.comARS Investment Partners LLC Buys New Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)ARS Investment Partners LLC bought a new position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 24,440 shares of the compJanuary 21, 2025 | marketbeat.comFY2029 Earnings Forecast for HRMY Issued By HC WainwrightHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - Investment analysts at HC Wainwright issued their FY2029 earnings per share estimates for Harmony Biosciences in a research report issued to clients and investors on Thursday, January 16th. HC Wainwright analyst P. Trucchio forecastJanuary 20, 2025 | marketbeat.comHarmony Biosciences stock reaffirms buy rating ahead of Q4 resultsJanuary 17, 2025 | msn.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Sells $388,864.07 in StockJanuary 17, 2025 | insidertrades.comHennion & Walsh Asset Management Inc. Buys 20,798 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Hennion & Walsh Asset Management Inc. lifted its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 38.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 75,072 shares of the company's stock afJanuary 17, 2025 | marketbeat.comHarmony Biosciences shares ‘attractive’ at current levels, says H.C. WainwrightJanuary 17, 2025 | markets.businessinsider.comHarmony Biosciences: Strong Market Performance and Promising Prospects Justify Buy RatingJanuary 17, 2025 | markets.businessinsider.comHarmony Biosciences officer sells shares worth $388,840January 16, 2025 | msn.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Jeffrey Dierks Sells 10,507 SharesHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) insider Jeffrey Dierks sold 10,507 shares of the firm's stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $37.01, for a total value of $388,864.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.January 16, 2025 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Earns Buy Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $75.00 price objective on shares of Harmony Biosciences in a research report on Thursday.January 16, 2025 | marketbeat.comHarmony Biosciences price target raised to $32 from $31 at BofAJanuary 14, 2025 | markets.businessinsider.comHarmony Biosciences Holdings (HRMY) Receives a Sell from Bank of America SecuritiesJanuary 14, 2025 | markets.businessinsider.comJPMorgan Chase & Co. Purchases 93,622 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)JPMorgan Chase & Co. grew its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 68.4% in the third quarter, according to its most recent filing with the SEC. The fund owned 230,428 shares of the company's stock after acquiring an additional 93,622 shares during the perioJanuary 14, 2025 | marketbeat.comHarmony Biosciences sees Q4 revenue $201M, consensus $198.6MJanuary 14, 2025 | markets.businessinsider.comSteady Performance and Reliable Growth Prospects Justify Buy Rating for Harmony BiosciencesJanuary 13, 2025 | markets.businessinsider.comHarmony Biosciences Anticipates Revenue Growth In Q4, FY24; Stock UpJanuary 13, 2025 | markets.businessinsider.comHarmony Biosciences (NASDAQ:HRMY) Shares Gap Up - Time to Buy?Harmony Biosciences (NASDAQ:HRMY) Shares Gap Up - Still a Buy?January 13, 2025 | marketbeat.comNeedham & Company LLC Reaffirms Buy Rating for Harmony Biosciences (NASDAQ:HRMY)Needham & Company LLC restated a "buy" rating and issued a $52.00 target price on shares of Harmony Biosciences in a report on Monday.January 13, 2025 | marketbeat.comHarmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline CatalystsJanuary 13, 2025 | finance.yahoo.comPrincipal Financial Group Inc. Lowers Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Principal Financial Group Inc. trimmed its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 10.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 162,469 shares oJanuary 2, 2025 | marketbeat.comHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Moderate Buy" by BrokeragesHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Get Free Report) has earned an average recommendation of "Moderate Buy" from the ten analysts that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation and eight have given a buy recommendaDecember 28, 2024 | marketbeat.comHarmony Biosciences (NASDAQ:HRMY) Trading Down 2.3% - What's Next?Harmony Biosciences (NASDAQ:HRMY) Stock Price Down 2.3% - What's Next?December 24, 2024 | marketbeat.comBarclays PLC Increases Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)Barclays PLC grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 110.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 76,862 shares of the company's stock afteDecember 24, 2024 | marketbeat.comHarmony Biosciences to Present at 43rd Annual J.P. Morgan Healthcare ConferenceDecember 23, 2024 | msn.comFY2024 Earnings Estimate for HRMY Issued By HC WainwrightHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) - Equities researchers at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for Harmony Biosciences in a note issued to investors on Tuesday, December 17th. HC Wainwright analyst P. Trucchio anticipates that the comDecember 20, 2024 | marketbeat.com Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address HRMY Media Mentions By Week HRMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HRMY News Sentiment▼0.670.69▲Average Medical News Sentiment HRMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HRMY Articles This Week▼185▲HRMY Articles Average Week Get Harmony Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HRMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Roivant Sciences News Ascendis Pharma A/S News Blueprint Medicines News BridgeBio Pharma News Lantheus News Revolution Medicines News Legend Biotech News Elanco Animal Health News Nuvalent News Cytokinetics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HRMY) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harmony Biosciences Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harmony Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
